Menstrual Relief Multi-Symptom Interactions
There are 506 drugs known to interact with Menstrual Relief Multi-Symptom (acetaminophen / pamabrom / pyrilamine), along with 11 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 19 are major, 473 are moderate, and 14 are minor.
- View all 506 medications that may interact with Menstrual Relief Multi-Symptom
- View Menstrual Relief Multi-Symptom alcohol/food interactions (1)
- View Menstrual Relief Multi-Symptom disease interactions (11)
Most frequently checked interactions
View interaction reports for Menstrual Relief Multi-Symptom (acetaminophen / pamabrom / pyrilamine) and the medicines listed below.
- Abilify (aripiprazole)
- Abilify (aripiprazole)
- acetaminophen
- acetaminophen
- bismuth subsalicylate
- bismuth subsalicylate
- buspirone
- buspirone
- calcium carbonate
- calcium carbonate
- chlorhexidine topical
- chlorhexidine topical
- clonazepam
- clonazepam
- cranberry
- cranberry
- diphenhydramine
- diphenhydramine
- elderberry
- elderberry
- Emetrol (phosphorated carbohydrate solution)
- Emetrol (phosphorated carbohydrate solution)
- escitalopram
- escitalopram
- Iron Gluconate (ferrous gluconate)
- Iron Gluconate (ferrous gluconate)
- Kyleena (levonorgestrel)
- Kyleena (levonorgestrel)
- Lactaid (lactase)
- Lactaid (lactase)
Menstrual Relief Multi-Symptom alcohol/food interactions
There is 1 alcohol/food interaction with Menstrual Relief Multi-Symptom (acetaminophen / pamabrom / pyrilamine).
Menstrual Relief Multi-Symptom disease interactions
There are 11 disease interactions with Menstrual Relief Multi-Symptom (acetaminophen / pamabrom / pyrilamine) which include:
- alcoholism
- liver disease
- depression
- PKU
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- glaucoma
- liver disease
- hypokalemia
More about Menstrual Relief Multi-Symptom (acetaminophen / pamabrom / pyrilamine)
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.